Rheumatoid Arthritis
Conditions
Interventions
HP(-) group:All patients were routinely treated with methotrexate (MTX), leflunomide, and nonsteroidal anti-inflammatory drugs.
Anti-HP group:Methotrexate (MTX), leflunomide, and non-steroidal anti-inflammatory drugs were routinely given. The anti-HP group was additionally given anti-HP treatment. The drugs used were: amoxicil
contral group:The control group did not use antibiotics or bismuth during the study period.
Sponsors
Qingdao Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
27 Years to 91 Years
Inclusion criteria
Inclusion criteria: (1) Comply with Western medicine diagnostic standards; (2) Meet the diagnostic standards of traditional Chinese medicine; (3) Aged over 18 years old
Exclusion criteria
Exclusion criteria: (1) Those who do not meet the inclusion criteria; (2) Pregnant or lactating women; (3) Combined with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system; (4) Overlapping patients with other rheumatic diseases such as systemic lupus erythematosus, Sjogren's syndrome, severe osteoarthritis, etc.; (5) Those who have intellectual and cognitive disabilities or are older and unable to answer questions accurately (6) Combined with serious infections, infectious diseases (such as hepatitis B, active tuberculosis), and tumor diseases; (7) Those whose joint function has been affected by recent surgery, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| dialectical classification;TCM syndrome score;DAS28 score;erythrocyte sedimentation rate;C-reactive protein;anti-CCP antibodies;Rheumatoid factor; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood routine;Liver function; | — |
Countries
China
Contacts
Public ContactHua Zhao
Qingdao Traditional Chinese Medicine Hospital
Outcome results
None listed